Results
4092
Companies which are more than 50% undervalued based on analyst price target.
4,092 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
MAC | UK£0.021 | -39.4% | 43.3% | UK£2.3m | UK£1.30 | PS4.6x | n/a | n/a | Diversified Financials | ||
NDRA | US$5.40 | 5.9% | -99.7% | US$2.7m | US$2,625.00 | PB0.4x | E-16.8% | n/a | Healthcare | ||
SNAX | US$0.72 | -3.2% | -53.8% | US$2.7m | US$4.00 | PS0.1x | n/a | n/a | Food, Beverage & Tobacco | ||
DRMA | US$1.22 | 1.7% | -81.5% | US$2.6m | US$6.00 | PB0.5x | E-14.0% | n/a | Pharmaceuticals & Biotech | ||
AUUD | US$0.46 | -2.7% | -92.0% | US$2.6m | US$25.00 | PB0.4x | E5.9% | n/a | Software | ||
ATXI | US$1.30 | -1.5% | -87.7% | US$2.6m | US$8.00 | PB1x | E46.2% | n/a | Pharmaceuticals & Biotech | ||
QNRX | US$0.32 | 10.8% | -90.4% | US$2.5m | US$4.50 | PB0.5x | E57.0% | n/a | Pharmaceuticals & Biotech | ||
SMK | UK£0.035 | 0% | 0% | UK£2.0m | UK£0.81 | PS0.1x | n/a | n/a | Retail | ||
MYSZ | US$1.91 | 1.6% | -45.7% | US$2.5m | US$3.00 | PS0.2x | S8.5% | n/a | Software | ||
FRX | AU$0.005 | 0% | -79.2% | AU$3.9m | AU$0.079 | PS0.3x | S36.7% | n/a | Telecom | ||
MAXENT B | SEK 0.53 | -8.7% | -88.0% | SEK 26.9m | SEK 1.15 | PS0.02x | E54.0% | n/a | Media | ||
BDRX | US$4.17 | -1.7% | -87.2% | US$2.4m | US$18.05 | PS23.5x | S-97.7% | n/a | Pharmaceuticals & Biotech | ||
MPT | €0.29 | 22.5% | -28.3% | €2.3m | €0.70 | n/a | n/a | n/a | Software | ||
AZTR | US$0.39 | 53.2% | -98.7% | US$2.3m | US$3.50 | PS30.2x | E22.6% | n/a | Pharmaceuticals & Biotech | ||
CMB | CA$0.02 | 0% | -33.3% | CA$3.3m | CA$0.12 | PB9.1x | n/a | n/a | Materials | ||
CL8 | AU$0.013 | 0% | -7.1% | AU$3.5m | AU$0.079 | PS1x | E55.2% | n/a | Transportation | ||
SLXN | US$1.44 | -29.8% | -98.5% | US$2.2m | US$9.00 | n/a | E-9.5% | n/a | Pharmaceuticals & Biotech | ||
TD | €0.11 | -21.8% | -56.5% | €2.1m | €0.22 | PS0.1x | S3.4% | n/a | Retail | ||
CMOTEC B | SEK 1.01 | -2.9% | -66.1% | SEK 23.6m | SEK 3.10 | PS4.7x | E29.0% | n/a | Healthcare | ||
ATORX | SEK 0.03 | -7.4% | -97.2% | SEK 22.8m | SEK 2.50 | PS0.4x | n/a | n/a | Pharmaceuticals & Biotech | ||
TAST | UK£0.0085 | 0% | -22.7% | UK£1.7m | UK£0.039 | PE0.3x | E-82.7% | n/a | Consumer Services | ||
TCBP | US$0.23 | -27.4% | -97.4% | US$2.1m | US$2.40 | PB0.8x | E-10.1% | n/a | Pharmaceuticals & Biotech | ||
APVO | US$4.31 | -3.4% | -98.2% | US$2.1m | US$21.00 | PB0.5x | E33.5% | n/a | Pharmaceuticals & Biotech | ||
LGMK | US$0.97 | -18.2% | -96.1% | US$2.0m | US$4.00 | PS0.2x | n/a | n/a | Healthcare |